Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a cross-sectional observational study in primary care

被引:6
作者
Sluga, Romina [1 ,2 ]
Smeele, Ivo J. M. [3 ,4 ]
Lucas, Annelies E. [5 ]
Thoonen, Bart P. [1 ,6 ]
Grootens-Stekelenburg, Joke G. [1 ]
Heijdra, Yvonne F. [7 ]
Schermer, Tjard R. [1 ]
机构
[1] Radboudumc, Dept Primary & Community Care, Nijmegen, Netherlands
[2] Univ Ljubljana, Med Fac Ljubljana, Dept Family Med, Ljubljana 61000, Slovenia
[3] COPD & Asthma Gen Practitioner Advisory Grp CAHAG, Utrecht, Netherlands
[4] SHL Grp, Etten Leur, Netherlands
[5] Diagnostiek U DCE, Eindhoven, Netherlands
[6] Gen Practice Lab Fdn East SHO, Velp, Netherlands
[7] Radboudumc, Dept Chest Dis, Nijmegen, Netherlands
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2014年 / 23卷 / 01期
关键词
airflow obstruction; chronic obstructive pulmonary disease; Primary care; spirometry; staging; LUNG-FUNCTION; REFERENCE VALUES; PULMONARY-DISEASE; ADULTS; PREVALENCE; HEALTH; COSTS; RISK;
D O I
10.4104/pcrj.2014.00006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Severity of airflow obstruction in chronic obstructive pulmonary disease (COPD) is based on forced expiratory volume in one second expressed as percentage predicted (FEV1%predicted) derived from reference equations for spirometry results. Aims: To establish how switching to new spirometric reference equations would affect severity staging of airflow obstruction in the Dutch primary care COPD patient population. Methods: Spirometry tests of 3,370 adults aged >= 40 years with obstruction (postbronchodilator FEV1/forced vital capacity (FVC) <0.70) were analysed. The presence and severity of obstruction were defined using Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Postbronchodilator FEV1%predicted was calculated using three reference equations: corrected European Community of Steel and Coal (ECSC) (currently recommended in Dutch primary care), Swanney et al., and Global Lung Initiative (GLI). Discordances between severity classifications based, on these equations were analysed. Results: We studied 1,297 (38.5%) females and 2,073 males. Application of contemporary reference equations (i.e. Swanney and GLI) changed the GOLD severity stages obtained with the ECSC equations, mostly into milder stages. Severity of airflow obstruction was staged differently in 14.0% and 6.3%, respectively, when the Swanney et al. and GLI reference equations were applied. Conclusions: Compared with the (corrected) ECSC equations, switching to more contemporary reference equations would result in lower FEV1 predicted values and affect interpretation of spirometry by reclassifying 6-14% of primary care COPD patients into different (mostly milder) severity stages. If and how this will affect GPs' treatment choices in individual patients with COPD requires further investigation. (C) 2014 Primary Care Respiratory Society UK. All rights reserved.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 50 条
  • [31] Validation of the global lung initiative 2012 multi-ethnic spirometric reference equations in healthy urban Zimbabwean 7-13 year-old school children: a cross-sectional observational study
    Madanhire, Tafadzwa
    Ferrand, Rashida A.
    Attia, Engi F.
    Sibanda, Elopy N.
    Rusakaniko, Simba
    Rehman, Andrea M.
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [32] Primary care access and its relationship with emergency department utilisation: an observational, cross-sectional, ecological study
    Harris, Matthew J.
    Patel, Brijesh
    Bowen, Simon
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (593) : e787 - e793
  • [33] Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study
    Thomas, Mike
    Murray-Thomas, Tarita
    Fan, Tao
    Williams, Tim
    Taylor, Stephanie
    [J]. BMC PULMONARY MEDICINE, 2010, 10
  • [34] Impact of the primary care curriculum and its teaching formats on medical students’ perception of primary care: a cross-sectional study
    Christopher Chung
    Hubert Maisonneuve
    Eva Pfarrwaller
    Marie-Claude Audétat
    Alain Birchmeier
    Lilli Herzig
    Thomas Bischoff
    Johanna Sommer
    Dagmar M. Haller
    [J]. BMC Family Practice, 17
  • [35] Impact of the primary care curriculum and its teaching formats on medical students' perception of primary care: a cross-sectional study
    Chung, Christopher
    Maisonneuve, Hubert
    Pfarrwaller, Eva
    Audetat, Marie-Claude
    Birchmeier, Alain
    Herzig, Lilli
    Bischoff, Thomas
    Sommer, Johanna
    Haller, Dagmar M.
    [J]. BMC FAMILY PRACTICE, 2016, 17
  • [36] What is the impact of primary care model type on specialist referral rates? A cross-sectional study
    Clare Liddy
    Jatinderpreet Singh
    Ryan Kelly
    Simone Dahrouge
    Monica Taljaard
    Jamie Younger
    [J]. BMC Family Practice, 15
  • [37] What is the impact of primary care model type on specialist referral rates? A cross-sectional study
    Liddy, Clare
    Singh, Jatinderpreet
    Kelly, Ryan
    Dahrouge, Simone
    Taljaard, Monica
    Younger, Jamie
    [J]. BMC FAMILY PRACTICE, 2014, 15
  • [38] The impact of COVID-19 on private and public primary care physicians: A cross-sectional study
    Lau, Jerrald
    Tan, David Hsien-Yung
    Wong, Gretel Jianlin
    Lew, Yii-Jen
    Chua, Ying-Xian
    Low, Lian-Leng
    Koh, Gerald Choon-Huat
    Kwek, Thiam-Soo
    Toh, Sue-Anne Ee-Shiow
    Tan, Ker-Kan
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (03) : 285 - 289
  • [39] Smoking cessation interventions for patients with coronary heart disease and comorbidities: an observational cross-sectional study in primary care
    Blane, David N.
    Mackay, Daniel
    Guthrie, Bruce
    Mercer, Stewart W.
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2017, 67 (655) : E118 - E129
  • [40] Prevalence and Characterization of Neuropathic Pain in a Primary-Care Setting in Spain A Cross-Sectional, Multicentre, Observational Study
    Perez, Concepcion
    Teresa Saldana, Maria
    Navarro, Ana
    Vilardaga, Inma
    Rejas, Javier
    [J]. CLINICAL DRUG INVESTIGATION, 2009, 29 (07) : 441 - 450